Phathom Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PHAT and other ETFs, options, and stocks.About PHAT
Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.
CEOSteven L. Basta
CEOSteven L. Basta
Employees427
Employees427
HeadquartersFlorham Park, New Jersey
HeadquartersFlorham Park, New Jersey
Founded2018
Founded2018
Employees427
Employees427
PHAT Key Statistics
Market cap1.09B
Market cap1.09B
Price-Earnings ratio-4.00
Price-Earnings ratio-4.00
Dividend yield—
Dividend yield—
Average volume758.32K
Average volume758.32K
High today$15.55
High today$15.55
Low today$14.96
Low today$14.96
Open price$15.15
Open price$15.15
Volume651.46K
Volume651.46K
52 Week high$16.45
52 Week high$16.45
52 Week low$2.21
52 Week low$2.21
Stock Snapshot
As of today, Phathom Pharmaceuticals(PHAT) shares are valued at $15.36. The company's market cap stands at 1.09B, with a P/E ratio of -4.00.
During the trading session on 2025-12-17, Phathom Pharmaceuticals(PHAT) shares reached a daily high of $15.55 and a low of $14.96. At a current price of $15.36, the stock is +2.7% higher than the low and still -1.2% under the high.
Trading activity shows a volume of 651.46K, compared to an average daily volume of 758.32K.
Over the past 52 weeks, Phathom Pharmaceuticals(PHAT) stock has traded between a high of $16.45 and a low of $2.21.
Over the past 52 weeks, Phathom Pharmaceuticals(PHAT) stock has traded between a high of $16.45 and a low of $2.21.
Analyst ratings
82%
of 11 ratingsBuy
81.8%
Hold
18.2%
Sell
0%
People also own
Based on the portfolios of people who own PHAT. This list is generated using Robinhood data, and it’s not a recommendation.